Ye Seul Yang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Glycemic Control

Cardiovascular Risk Factors

Skeletal Muscle

Top Venues

Diabetes, obesity & metabolism

Journal of lipid and atherosclerosis

Yonsei medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ye Seul Yang, Kyung Wan Min, Seok-O Park, Kyung-Soo Kim, Jae Myung Yu, Eun Gyoung Hong, Sung Rae Cho, Kyu Chang Won, Yong Hyun Kim, Seungjoon Oh, Sung Hee Choi, Gwanpyo Koh, Wan Huh, Su Young Kim, Kyong Soo Park
Efficacy and Safety of Monotherapy with Enavogliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results of a 12-week, multi-center, randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes, obesity & metabolism (2023)
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon, null null
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement. Journal of lipid and atherosclerosis 12 (1) (2023)
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon, null null
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement. Journal of lipid and atherosclerosis 12 (1) (2023)
Youngji Kim, Ye Seul Yang, Woonhyoung Lee, Man Jin Kim, Cheol Min Shin, Sung Hee Choi
Congenital Analbuminemia in a Korean Male Diagnosed with Single Nucleotide Polymorphism in the ALB Gene: The First Case Reported in Korea. Yonsei medical journal 60 (7) (2019)
Ye Seul Yang, Min Hyuk Lim, Seong Ok Lee, Min-Seon Kim, Chang Ho Ahn, Soo Heon Kwak, Young Min Cho, Sungwan Kim, Andrea Mari, Kyong Soo Park, Hye Seung Jung
Fimasartan increases glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine. Diabetes, obesity & metabolism 20 (7) (2018)